TERNION BIOSCIENCES PTE. LTD.
Last Updated: 13 Apr 2026
Ternion is a Singapore-based biotech startup CRO that aims to revolutionize the traditional approach to pre-clinical drug safety testing and pharmacovigilance. Our OptioQUANT platform utilizes human stem cell-based assays that are faster, more physiologically relevant, and cost-effective compared to animal-based studies. With expertise in human stem cells, tissue engineering, ion channels, electrophysiology, and advanced optical imaging, we provide high-quality research services for compound screening assays, toxicity studies, and more. By improving the speed, precision, and reproducibility of pre-clinical drug safety assays, we enable faster and more efficient drug development, resulting in significant time and cost savings for our clients.
Country of registration | Singapore |
Registration number | 201622954M |
Local SIC | |
Incorporation date | 23 Aug 2016 |
Company age | 9 years 9 months |
Official entity type | Exempt Private Limited Company |
No. of officers | 6 |
Contact
Address:
97C UPPER THOMSON ROAD, #20-09, LAKEVIEW ESTATE, Singapore 574329
Access Key Decision Makers
This is the legal entity page of TERNION BIOSCIENCES PTE. LTD.. To access company info, company size, news , key makers’ emails, visit the profile pages above.
Associated business (2)
- TERNION BIOSCIENCESView MoreSingaporeTernion is a Singapore-based biotech startup CRO that aims to revolutionize the traditional approach to pre-clinical drug safety testing and pharmacovigilance. Our OptioQUANT platform utilizes human stem cell-based assays that are faster, more physiologically relevant, and cost-effective compared to animal-based studies. With expertise in human stem cells, tissue engineering, ion channels, electrophysiology, and advanced optical imaging, we provide high-quality research services for compound screening assays, toxicity studies, and more. By improving the speed, precision, and reproducibility of pre-clinical drug safety assays, we enable faster and more efficient drug development, resulting in significant time and cost savings for our clients.
- E27 (OPTIMATIC)View MoreSingaporee27 is the go-to platform for connections, insights, and funding opportunities in the Southeast Asia startup ecosystem. Our mission is to empower entrepreneurs with the tools they need to build and grow their businesses across APAC. Stay up-to-date on the latest news and connect with key stakeholders through our platform. Whether you're a startup, investor, corporate, or government agency, e27 provides the resources and networking opportunities you need to achieve your business objectives.
This is the legal entity page of TERNION BIOSCIENCES PTE. LTD.. To access company info, company size, news, key maker's emails, visit the profile pages above.
Financials
Revenue | < 1m |
Share Capital - Ordinary shares | SGD 46,810 |
Last updated: 13 Apr 2026
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Discover More Companies
Lookalike companies
* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0. Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.
Frequently Asked Questions (FAQ)
- What is the address of TERNION BIOSCIENCES PTE. LTD.?
- Where is TERNION BIOSCIENCES PTE. LTD.'s headquarter?
- What is TERNION BIOSCIENCES PTE. LTD.'s contact number?
- What TERNION BIOSCIENCES PTE. LTD.'s spending power?
- Does TERNION BIOSCIENCES PTE. LTD. have a presence in the domain it operates in?